New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma

Neuroscience Letters

Volumn 336, Issue 1, 2003, Pages 29-32

  Parareda, Andreu ^a   Villaescusa, Juan Carlos ^a   Sanchez de Toledo, José ^a   Gallego, Soledad ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Alternative splicing; Minimal residual disease; Neuroblastoma; Tyrosine Hydroxylase

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE AMPLIFICATION; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; MOLECULAR CLONING; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ALTERNATIVE SPLICING; BASE SEQUENCE; BLOOD; BONE MARROW; EXONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASM, RESIDUAL; NEUROBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; TYROSINE 3-MONOOXYGENASE;

EID: 0037426717     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01220-X     Document Type: Article

References (15)

1. Burchill S.A., Bradbury F.M., Smith B., Lewis I.J., Selby P. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for Tyrosine Hydroxylase mRNA. Int. J. Cancer. 57:1994;671-675.
2. Davies B., Fried M. The L19 ribosomal protein gene (RPL19): gene organization, chromosomal mapping, and novel promoter region. Genomics. 25:1995;372-380.
3. Dumas S., Le Hir H., Bodeau-Péan S., Hirsch E., Thermes C., Mallet J. New species of Human Tyrosine Hydroxylase mRNA are produced in variable amounts in adrenal medulla and are overexpressed in Progressive Supranuclear Palsy. J. Neurochem. 67:1996;19-25.
4. Gallego S., Parareda A., Sanchez de Toledo J., Reventos J. Quantitative analysis of Tyrosine Hydroxylase gene expression in neuroblastoma. Med. Pediatr. Oncol. 35:2000;734.
5. Grima B., Lamouroux A., Boni C., Julien J.F., Javoy-Agid F., Mallet J. A single human gene encoding multiple Tyrosine Hydroxylase with different predicted functional characteristics. Nature. 326:1987;707-711.
6. Haycock J.W. Four forms of Tyrosine Hydroxylase are present in Human Adrenal Medulla. J. Neurochem. 56:1991;2139-2142.
7. Kaneda N., Kobayashi K., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., Nagatsu T. Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem. Biophys. Res. Commun. 146:1987;971-975.
8. Kobayashi K., Kaneda N., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., Nagatsu T. Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J. Biochem. 103:1988;907-912.
9. D2 immunocytochemistry. Eur. J. Cancer. 33:1997;2024-2030.
10. Miyajima Y., Kato K., Numata S., Kudo K., Horibe K. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for Tyrosine Hydroxylase mRNA. Cancer. 75:1995;2757-2761.
11. Naito H., Kuzumaki N., Uchino J., Kobayashi R., Shikano T., Ishikawa Y., Matsumoto S. Detection of Tyrosine Hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur. J. Cancer. 27:1991;762-765.
12. Ohye T., Ichinose H., Yoshizawa T., Kanazawa I., Nagatsu T. A new splicing variant for Human Tyrosine Hydroxylase in the adrenal medulla. Neurosci. Lett. 312:2001;157-160.
13. O'Malley K.L., Anhalt M.J., Martin B.M., Kelsoe J.R., Winfield S.L., Ginns E.I. Isolation and characterization of the Human Tyrosine Hydroxylase gene: identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry. 26:1987;6910-6914.
14. TchÍrkov A., Kanold J., Giollant M., Halle-Haus P., Berger M., Rapatel C., Lutz P., Bergeron C., Plantaz D., Vannier J.P., Stephan J.L., Favrot M., Bordigoni P., Malet P., Briancon G., Demeocq F. Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selection. Med. Pediatr. Oncol. 30:1998;228-232.
15. Vrana K.E., Walker S.J., Rucker P., Liu X. A carboxyl terminal leucine zipper is required for Tyrosine Hydroxylase tetramer formation. J. Neurochem. 63:1994;2014-2020.